Neuropace Inc

NASDAQ:NPCEUnited States

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.

Contact Information

Headquarters

455 N. Bernardo AvenueMOUNTAIN VIEW, CA, United States 94043

Phone

650-237-2700

Fax

650-237-2701

Executives

Independent Chairman of the Board

Frank Fischer

President, Chief Executive Officer, Director

Joel Becker

Chief Financial Officer, Vice President of Finance and Administration, Corporate Secretary

Rebecca Kuhn

Vice President - Marketing

Katie Keller

Vice President - Research and Development

Brett Wingeier